What is NDC 68788-8843?

68788-8843 is the product NDC for Levetiracetam, Levetiracetam 500 mg/1 tablet, listed with the FDA by Preferred Pharmaceuticals Inc.. It has 5 package NDCs, shown above in 10- and 11-digit form.

Preferred Pharmaceuticals Inc., NDC labeler code 68788. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Levetiracetam?

261 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Levetiracetam NDC 68788-8843 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68788-8843Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68788-8843Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
68788-8843-1	68788884301	100 TABLET in 1 BOTTLE (68788-8843-1)Marketed from Mar 20, 2025
68788-8843-2	68788884302	20 TABLET in 1 BOTTLE (68788-8843-2)Marketed from Mar 20, 2025
68788-8843-3	68788884303	30 TABLET in 1 BOTTLE (68788-8843-3)Marketed from Mar 20, 2025
68788-8843-6	68788884306	60 TABLET in 1 BOTTLE (68788-8843-6)Marketed from Mar 20, 2025
68788-8843-9	68788884309	90 TABLET in 1 BOTTLE (68788-8843-9)Marketed from Mar 20, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Levetiracetam
Generic name (nonproprietary): levetiracetam
Active ingredients: Levetiracetam — 500 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Preferred Pharmaceuticals Inc.NDC labeler code 68788
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091491
Marketing start: Mar 20, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 68788-8843_8c16bc7b-672c-420a-a457-350060533375SPL ID 8c16bc7b-672c-420a-a457-350060533375SPL set ID 8c16bc7b-672c-420a-a457-350060533375RxCUI 311289UNII 44YRR34555

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468788884301 followed by a unit qualifier and the quantity

Package 68788-8843-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 20, 2025.

Indications (excerpt from the label)

Levetiracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older (1.1) Levetiracetam is indicated for adjunctive therapy for the treatment of: • Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy (1.2) • Primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy (1.3) 1.1 Partial-Onset Seizures Levetiracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. 1.2 Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy Levetiracetam is indicated as adjunctive therapy for the treatment of myoclonic seizures…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68788-8843

What is NDC 68788-8843?: 68788-8843 is the product NDC for Levetiracetam, Levetiracetam 500 mg/1 tablet, listed with the FDA by Preferred Pharmaceuticals Inc.. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Levetiracetam.
What is the active ingredient?: Levetiracetam.
Who is the labeler?: Preferred Pharmaceuticals Inc., NDC labeler code 68788. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Levetiracetam?: 261 other product NDCs are listed under this name. See all Levetiracetam NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Levetiracetam NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Levetiracetam	Levetiracetam 500 mg/1	Tablet, Film coatedOral	Cardinal Health 107, LLC	55154-0288	55154-0288-00
Levetiracetam	Levetiracetam 750 mg/1	Tablet, Film coated, Extended releaseOral	REMEDYREPACK INC.	70518-4731	70518-4731-00
Levetiracetam	Levetiracetam 100 mg/mL	Injection, Solution, ConcentrateIntravenous	Baxter Healthcare Corporation	36000-265	36000-0265-0536000-0265-10
Levetiracetam	Levetiracetam 1000 mg/1	TabletOral	Direct_Rx	72189-679	72189-0679-6072189-0679-82
Levetiracetam	Levetiracetam 500 mg/1	Tablet, Film coatedOral	Unit Dose Solutions, Inc.	87441-046	87441-0046-01
Levetiracetam	Levetiracetam 500 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0420	67046-0420-03
Levetiracetam	Levetiracetam 500 mg/1	Tablet, Film coatedOral	Injecta Medcial LLC	87234-0035	87234-0035-01
Levetiracetam	Levetiracetam 1000 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0863	67046-0863-03
Levetiracetam	Levetiracetam 500 mg/1	TabletOral	Coupler LLC	67046-2094	67046-2094-03
Levetiracetam	Levetiracetam 250 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0880	67046-0880-03

All 262 Levetiracetam NDCs

Other NDCs under ANDA 091491

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091491
Product	Strength	Form · route	Labeler	Product NDC
Levetiracetam	Levetiracetam 500 mg/1	TabletOral	Advanced Rx of Tennessee, LLC	80425-0565
Levetiracetam	Levetiracetam 500 mg/1	TabletOral	Advanced Rx of Tennessee, LLC	80425-0566
Levetiracetam	Levetiracetam 750 mg/1	TabletOral	REMEDYREPACK INC.	70518-4013
Levetiracetam	Levetiracetam 250 mg/1	TabletOral	Bryant Ranch Prepack	71335-2275
Levetiracetam	Levetiracetam 500 mg/1	TabletOral	A-S Medication Solutions	50090-7521
Levetiracetam	Levetiracetam 750 mg/1	TabletOral	Coupler LLC	67046-1207
Levetiracetam	Levetiracetam 500 mg/1	TabletOral	A-S Medication Solutions	50090-7820
Levetiracetam	Levetiracetam 500 mg/1	TabletOral	Bryant Ranch Prepack	71335-9757
Levetiracetam	Levetiracetam 250 mg/1	TabletOral	Cranbury Pharmaceuticals, LLC	27808-263
Levetiracetam	Levetiracetam 500 mg/1	TabletOral	Cranbury Pharmaceuticals, LLC	27808-264
Levetiracetam	Levetiracetam 750 mg/1	TabletOral	Cranbury Pharmaceuticals, LLC	27808-265
Levetiracetam	Levetiracetam 1000 mg/1	TabletOral	Cranbury Pharmaceuticals, LLC	27808-266
Levetiracetam	Levetiracetam 250 mg/1	TabletOral	ASCLEMED USA INC.	87063-190
Levetiracetam	Levetiracetam 500 mg/1	TabletOral	ASCLEMED USA INC.	87063-191
Levetiracetam	Levetiracetam 750 mg/1	TabletOral	ASCLEMED USA INC.	87063-192
Levetiracetam	Levetiracetam 1000 mg/1	TabletOral	ASCLEMED USA INC.	87063-193
Levetiracetam	Levetiracetam 1000 mg/1	TabletOral	Coupler LLC	67046-1461
Levetiracetam	Levetiracetam 500 mg/1	TabletOral	Coupler LLC	67046-2094
Levetiracetam	Levetiracetam 1000 mg/1	TabletOral	Direct_Rx	72189-679
Levetiracetam	Levetiracetam 1000 mg/1	TabletOral	REMEDYREPACK INC.	70518-3895

Showing 20 of 22.